Correlation Between Hemostemix and Telo Genomics

Can any of the company-specific risk be diversified away by investing in both Hemostemix and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hemostemix and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hemostemix and Telo Genomics Corp, you can compare the effects of market volatilities on Hemostemix and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hemostemix with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hemostemix and Telo Genomics.

Diversification Opportunities for Hemostemix and Telo Genomics

0.22

Correlation Coefficient

Hemostemix  Telo Genomics

Modest diversification

The 3 months correlation between Hemostemix and Telo is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Hemostemix and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Hemostemix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hemostemix are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Hemostemix i.e., Hemostemix and Telo Genomics go up and down completely randomly.

Pair Corralation between Hemostemix and Telo Genomics

Assuming the 90 days horizon Hemostemix is expected to under-perform the Telo Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Hemostemix is 1.73 times less risky than Telo Genomics. The stock trades about -0.01 of its potential returns per unit of risk. The Telo Genomics Corp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  9.10  in Telo Genomics Corp on September 19, 2024 and sell it today you would lose (1.03) from holding Telo Genomics Corp or give up 11.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.65%
Values	Daily Returns

Hemostemix  vs.  Telo Genomics Corp

Hemostemix

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Hemostemix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Hemostemix showed solid returns over the last few months and may actually be approaching a breakup point.

Telo Genomics Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Hemostemix and Telo Genomics

The main advantage of trading using opposite Hemostemix and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hemostemix position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.

The idea behind Hemostemix and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.